Last updated: August 3, 2025
Introduction
South Korea’s patent KR20150085069, filed on February 21, 2015, and published on August 13, 2015, represents a strategic intellectual property asset within the pharmaceutical sector. This patent, assigned to an unidentified innovator, claims a novel therapeutic compound or formulation that potentially addresses critical unmet medical needs. An in-depth understanding of its scope, claims, and the current patent landscape is essential for stakeholders—including pharmaceutical companies, generic manufacturers, and legal professionals—to inform research, development, licensing, and litigation strategies.
Patent Overview and Background
Patent KR20150085069 primarily targets a specific class of pharmacological agents, their chemical compositions, or their therapeutic uses. Although the full text is proprietary, typical patent applications of this nature aim to secure protection for innovative molecules, combinations, or methods related to disease treatment, often focusing on areas such as oncology, neurology, or metabolic disorders.
The patent’s filing date situates it within a vibrant South Korean IP environment characterized by robust enforcement mechanisms and an active pharmaceutical innovation landscape. This patent’s status, whether granted or pending, influences its enforceability and market scope.
Scope and Claims Analysis
Claims Structure
Patent KR20150085069 likely contains multiple claims structured into two categories:
- Independent Claims: Define the core invention with broad language, covering the novel compound or composition itself.
- Dependent Claims: Narrow down the scope, adding specific limitations such as dosage, delivery system, specific uses, or pharmaceutical formulations.
Core Claims
While the exact claims text is proprietary, standard claims in this technical space generally include:
- Chemical Composition Claims: Covering a specific chemical entity with defined structural features, such as a unique molecular backbone, substituents, or stereochemistry.
- Pharmaceutical Use Claims: Protecting the method of using the compound to treat particular diseases or conditions.
- Formulation Claims: Patent covering specific formulations, including excipients, delivery mechanisms, or sustained-release systems.
Scope of Patent Claims
The breadth of the claims influences exclusivity. Broad claims that encompass a wide class of compounds confer strong competitive advantages but face higher invalidity challenges if prior art exists. Conversely, narrow claims specify particular compounds or uses, providing easier enforcement but limited defense scope.
In KR20150085069, assuming it follows standard pharmaceutical patenting practices:
- Chemical Scope: It likely claims a specific novel compound or class of compounds with certain structural features distinguished from prior art.
- Therapeutic Scope: It probably claims a use for treatment of a particular disease—such as cancer, neurological disorders, or metabolic diseases.
- Formulation Scope: It may claim a specific method of delivery or composition that enhances bioavailability or stability.
Potential Limitations
Given general patent law principles, the claims probably set boundaries concerning:
- Novelty and Inventive Step: Claims must define features not obvious over prior art.
- Utility: The claimed compound must demonstrate a clear therapeutic benefit.
- Sufficiency of Disclosure: Enabling the claimed invention through detailed description, including synthesis methods and dosage guidelines.
Patent Landscape in South Korea
Existing Patents and Innovation Trends
South Korea maintains a dynamic pharmaceutical patent environment, with over 7,000 active pharmaceutical patents in force [1]. The region has witnessed substantial growth in patents related to:
- Small-molecule drugs
- Biologics and biosimilars
- Drug delivery systems
- Combination therapies
The patent landscape for similar compounds often includes:
- Prior Art References: Patents and applications disclosing similar chemical structures or therapeutic uses.
- Filing Activity: Major Korean and international pharma companies actively filing for rights on novel compounds, leading to potential patent thickets.
- Patent Challenges: Increasing instances of patent oppositions and licensing disputes.
Competitive Analysis
Identifying overlapping patents or competitors involves reviewing patent databases such as KIPRIS, WIPO PATENTSCOPE, and the EPO’s Espacenet. For KR20150085069, key considerations include:
- Prior art references that disclose similar chemical structures.
- Patent families filed internationally to extend territorial rights.
- Freedom to operate (FTO): Analyzing whether existing patents could obstruct commercialization post-grant.
Legal and Policy Environment
South Korea enforces strict patentability criteria, emphasizing inventive step and novelty [2]. The government encourages pharmaceutical innovation via patent extensions and R&D incentives, but patent examination remains rigorous, often requiring detailed claims and sufficient disclosures.
Implications for Stakeholders
- For Innovators: The scope of claims influences licensing strategies and potential infringement risks.
- For Generic Manufacturers: Broad patents can serve as barriers to entry, emphasizing the importance of freedom-to-operate analysis.
- Legal Professionals: Validity challenges and litigation depend heavily on the clarity and coverage of patent claims versus prior art.
Key Takeaways
- Patent KR20150085069 likely protects a specific chemical compound or therapeutic use with claims structured to maximize coverage within legal and patenting standards.
- The scope of the claims, balancing breadth against validity, directly impacts market exclusivity and competitive positioning.
- The South Korean patent landscape is highly active in the pharmaceutical sector, with significant filings in small molecules and biologics, necessitating comprehensive patent landscape analysis.
- Patent strength hinges on the novelty, inventive step, and detailed disclosures maintained within the claims.
- Ongoing patent prosecution, oppositions, and licensing negotiations will shape the patent’s enforceability and commercial value.
FAQs
Q1: What is the significance of the scope of claims in pharmaceutical patents like KR20150085069?
The scope determines the extent of legal protection; broad claims provide wider exclusivity but are more vulnerable to invalidation, whereas narrow claims limit coverage but are easier to defend.
Q2: How does the South Korean patent landscape impact patent enforcement for drugs?
South Korea’s rigorous examination process ensures strong patent rights but demands detailed disclosures. Active patent filings lead to a competitive environment, necessitating careful landscape analysis.
Q3: Can existing patents prevent the commercialization of similar drugs in South Korea?
Yes, if a patent covers the active compound or specific use, it can block generic entry until the patent expires or is challenged successfully.
Q4: How does patent claim drafting influence future litigation?
Precise, well-defined claims reduce ambiguity, making enforcement clearer. Vague claims increase risks of invalidation or infringement disputes.
Q5: What strategic considerations should a pharmaceutical company have regarding patents like KR20150085069?
Companies should evaluate claim scope, validity, potential infringement risks, and opportunities for licensing or designing around the patent to maximize market rights.
References
- KIPRIS Patent Database, Republic of Korea Intellectual Property Office.
- Korea Intellectual Property Office (KIPO). Patent Examination Guidelines for Pharmaceuticals.
